US2017267632A1PendingUtilityA1
Methionine analogs and methods of using same
Assignee: BIOXINESS PHARMACEUTICALS INCPriority: Aug 1, 2008Filed: Jun 1, 2017Published: Sep 21, 2017
Est. expiryAug 1, 2028(~2.1 yrs left)· nominal 20-yr term from priority
C07C 323/60A61P 31/04A61P 31/12C07C 323/66A61P 31/10C07C 259/06A61P 31/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and/or antiviral properties. Also provided are methods of treatment and methods of preparation, as well as kits and unit dosages.
Claims
exact text as granted — not AI-modified1 - 151 . (canceled)
152 . A method of treating a bacterial infection in an individual comprising administering to the individual an effective amount of a compound of the formula:
wherein
q is 1 or 2;
R 8 is hydrogen or C 1 -C 5 alkyl; and
C is an optionally substituted L-amino acid residue wherein said substituent is selected from the group consisting of hydroxyl, nitro, amino, cyano, halo, C 1 -C 4 haloalkyl, thiol, C 1 -C 4 thioalkyl, sulfonyl, thioamido, amidino, formyl, C 1 -C 4 alkyl, C 3 -C 9 cycloalkyl, C 1 -C 4 alkoxy, and C 1 -C 4 alkoxy-C 1 -C 4 alkyl;
or a pharmaceutically acceptable salt thereof or solvate of the foregoing.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.